Open AccessA case of pacemaker associated Aspergillus fumigatus endocarditis
Author(s) -
Ujjwayini Ray,
Soma Dutta,
Aftab Alam Khan
Publication year - 2022
Publication title -
journal of global infectious diseases (print)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 25
eISSN - 0974-8245
pISSN - 0974-777X
DOI - 10.4103/jgid.jgid_67_21
Subject(s) - endocarditis , medicine , aspergillus fumigatus , aspergillosis , pathogen , aspergillus , surgery , infective endocarditis , cardiology , intensive care medicine , microbiology and biotechnology , immunology , biology
The use of cardiovascular implantable electronic devices (CIED) is associated with improved quality of life and decreased fatal outcomes in patients with cardiac dysfunctions. As with all foreign devices that are inserted or implanted in the body, CIED also carries the risk of device-related infections. Infections account for <2% of the complications associated with CIED, and only about 2% of these are secondary to a fungal pathogen. The first case of Aspergillus endocarditis secondary to a transvenous pacing lead was reported in the 1980s, and a limited number of cases have been documented in the literature since then. Aspergillus endocarditis is a highly fatal disease and establishing the diagnosis sufficiently early is challenging. We here report a case of Aspergillus endocarditis secondary to permanent pacemaker insertion which was successfully treated following the establishment of the diagnosis using imaging studies and galactomannan assay.